Fetal Alcohol Damage Prevention Study
Prevention of Fetal Alcohol Damage Using Maternal Blood Markers
1 other identifier
interventional
612
1 country
1
Brief Summary
The goal of this study was to determine whether a series of blood markers of alcohol use obtained from alcohol using pregnant women could help them to change their behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 6, 2008
CompletedFirst Posted
Study publicly available on registry
June 12, 2008
CompletedJune 12, 2008
June 1, 2008
3.9 years
June 6, 2008
June 11, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease in drinking
during the pregnancy
Secondary Outcomes (1)
improved infant size
after pregnancy finished
Study Arms (1)
I
OTHERPregnant women are recruited and screened for alcohol use using a validated alcoholism screening questionnaire. Those who screen positive are then entered into the next phase of the study.
Interventions
The women who have positive alcohol screening questionnaires and a random sample of women who screen negative are entered into the next phase of the study. They have blood drawn for the markers of alcohol use, are told of the results and are given brief intervention about alcohol use.
Eligibility Criteria
You may qualify if:
- Pregnant women seen at one of the obstetric clinics in the study and willing to give a blood sample
You may not qualify if:
- over 36 week gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lewis B Holmes, M.D.
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 6, 2008
First Posted
June 12, 2008
Study Start
March 1, 2004
Primary Completion
February 1, 2008
Study Completion
February 1, 2008
Last Updated
June 12, 2008
Record last verified: 2008-06